Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Not Selling Yet, Cipla Opposes Capping MNC-led Buyouts Of Indian Firms

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Cipla Ltd. Chairman Yusuf K. Hamied has tried to temper nagging speculation over a possible sell-off to a global company like Merck & Co. or Takeda Pharmaceutical Co. Ltd. He emphatically denied holding any negotiations and claimed he has never been approached for a potential transaction
Advertisement

Related Content

Cipla Sees Growth In Product-Based Alliances; In Deal With Teva For Inhalers In Russia
Indian Govt Move To Scrutinize MNC Investments In Indian Firms Could have "Chilling" Effect
Indian Govt Move To Scrutinize MNC Investments In Indian Firms Could have "Chilling" Effect
Indian Govt. Move To Scrutinize MNC Investments In Indian Firms Could have "Chilling" Effect
Indian Govt. Move To Scrutinize MNC Investments In Indian Firms Could have "Chilling" Effect
Indian Pharma Lobby Begins Fresh Offensive For Cap On Foreign Investments Into Domestic Companies
Will The Next Teva Be From India? Global Scale, Product Mix, And A Strong Balance Sheet Can Trigger Big M&As By Indian Pharma
India Story Tempered? Government May Put Future Brownfield Buyouts Under Scrutiny; No Qualms On Greenfield Investments
Merck, Cipla Deny Deal Talks But The Charm Of The Indian Market Stokes Speculations
Merck, Cipla Deny Deal Talks But The Charm Of The Indian Market Stokes Speculations
Advertisement
UsernamePublicRestriction

Register

SC078853

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel